Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M. ET
August 23 2022 - 7:30AM
Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company"
or “Field Trip”), a global leader in psychedelic therapies,
announced today that it plans to release financial results for its
fiscal 2023 first quarter for the three-month period ended June 30,
2022, after market close on Monday, August 29, 2022.
The Company will conduct a conference call and
webcast to discuss its results the following morning, Tuesday,
August 30, 2022 at 8:30 a.m. ET. To access the call, please dial
1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the
U.S.) and provide conference ID 13732491. A live webcast of the
conference call can be accessed via the Events and Presentations
section of the Field Trip Health & Wellness Investor Relations
website here.
For those unable to attend the live call, a
telephonic replay will be available until 11:59 p.m. ET on Tuesday,
September 13 2022. To access the replay dial 1-844-512-2921 (within
the U.S.) or 1-412-317-6671 (outside the U.S.) and provide
conference ID 13732491. The webcast will be archived and available
in the Events and Presentations section of the Field Trip Health
& Wellness Investor Relations website approximately one hour
after the conclusion of the live call.
About Field Trip Health & Wellness
Ltd.
Field Trip Health & Wellness Ltd. is a
global leader in psychedelic therapies. With health centres across
North America and Europe, along with the digital and technological
tools that will enable massive scale, we help people in need with a
simple, evidence-based way to heal and heighten engagement with the
world.
Learn more at https://www.meetfieldtrip.com,
https://www.fieldtriphealth.com and
https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth.
Cautionary Note Regarding
Forward-Looking Information
This release includes forward-looking
information (within the meaning of Canadian securities laws and
within the meaning of the United States Private Securities
Litigation Reform Act of 1995) regarding the Company and its
business. Often but not always, forward-looking information can be
identified by the use of words such as "expect", "intends",
"anticipated", "believes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would" or "will" be
taken, occur or be achieved. Such statements are based on the
current expectations and views of future events of the management
of the Company and are based on assumptions and subject to risks
and uncertainties. Although the management of believes that the
assumptions underlying these statements are reasonable, they may
prove to be incorrect. The forward-looking events and circumstances
discussed in this release may not occur and could differ materially
as a result of known and unknown risk factors and uncertainties
affecting the companies. Although the Company has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. Accordingly, readers should not place undue
reliance on any forward-looking statements or information. No
forward-looking statement can be guaranteed. Except as required by
applicable securities laws, forward-looking statements speak only
as of the date on which they are made and the Company does not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise. Additional information relating to the
Company, can be located on the SEDAR website at www.sedar.com.
Neither TSX Venture Exchange, or its Regulation
Services Provider, have approved the contents of this release or
accept responsibility for the adequacy or accuracy of this
release.
CONTACTS:
Field Trip Health & Wellness:Ronan
LevyChairman & CEO (416) 505-0929ronan@fieldtriphealth.com
Investor contacts:Phil Carlson / Sophia
Bashford KCSA Strategic Communications(646) 573-0776 / (929)
246-7307fieldtripIR@kcsa.com
SOURCE Field Trip Health & Wellness Ltd.
Field Trip Health and We... (TSXV:FTHW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Field Trip Health and We... (TSXV:FTHW)
Historical Stock Chart
From Jul 2023 to Jul 2024